Advertisement
U.S. markets close in 1 hour 59 minutes

MEI Pharma, Inc. (MEIP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.9927+0.0427 (+1.08%)
As of 01:50PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/28/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
26.12M38.64M46.71M43.84M30.50M32.46M
Enterprise Value
-21.33M-31.18M-41.26M-55.14M-80.30M-92.22M
Trailing P/E
1.320.94N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.360.370.960.750.490.76
Price/Book (mrq)
0.440.471.901.280.630.87
Enterprise Value/Revenue
-0.29N/A-0.63-37.85-13.62-2.82
Enterprise Value/EBITDA
-1.312.63-0.755.024.93-10.23

Trading Information

Stock Price History

Beta (5Y Monthly) 0.65
52-Week Change 3-14.78%
S&P500 52-Week Change 329.57%
52 Week High 37.9700
52 Week Low 33.4600
50-Day Moving Average 34.2886
200-Day Moving Average 36.0059

Share Statistics

Avg Vol (3 month) 324.35k
Avg Vol (10 day) 317.85k
Shares Outstanding 56.66M
Implied Shares Outstanding 66.74M
Float 84.94M
% Held by Insiders 10.55%
% Held by Institutions 147.60%
Shares Short (Mar 15, 2024) 49.1k
Short Ratio (Mar 15, 2024) 40.32
Short % of Float (Mar 15, 2024) 40.16%
Short % of Shares Outstanding (Mar 15, 2024) 40.14%
Shares Short (prior month Feb 15, 2024) 410.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 06, 2023
Ex-Dividend Date 4Nov 16, 2023
Last Split Factor 21:20
Last Split Date 3Apr 17, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 27.31%
Operating Margin (ttm)20.67%

Management Effectiveness

Return on Assets (ttm)8.30%
Return on Equity (ttm)36.79%

Income Statement

Revenue (ttm)72.65M
Revenue Per Share (ttm)10.90
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 15.38M
Net Income Avi to Common (ttm)19.84M
Diluted EPS (ttm)2.9800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.48M
Total Cash Per Share (mrq)8.93
Total Debt (mrq)12.03M
Total Debt/Equity (mrq)20.22%
Current Ratio (mrq)8.23
Book Value Per Share (mrq)8.93

Cash Flow Statement

Operating Cash Flow (ttm)-52.98M
Levered Free Cash Flow (ttm)433.62k